Enlaza Therapeutics’ $100 Million Series A Financing Round

Wilson Sonsini Goodrich & Rosati advised Enlaza on IP matters related to the transaction.Enlaza Therapeutics (Enlaza), the first covalent biologic platform company, announced it closed a…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now